Works by Delea, Thomas E.

Results: 48

Cost effectiveness of letrozole versus anastrozole in postmenopausal women with HR+ early-stage breast cancer.

Published in:

2010

By:

Michael Lipsitz;
Thomas E. Delea;
Amy Guo;
Lipsitz, Michael;
Delea, Thomas E;
Guo, Amy

Publication type:

journal article

Overall Survival Endpoint in Oncology Clinical Trials: Addressing the Effect of Crossover - The Case of Pazopanib in Advanced Renal Cell Carcinoma.

Published in:

Oncology, 2016, v. 90, n. 3, p. 119, doi. 10.1159/000443647

By:

Diaz, Jose;
Sternberg, Cora N.;
Mehmud, Faisal;
Delea, Thomas E.;
Latimer, Nicholas;
Pandite, Lini;
Motzer, Robert J.

Publication type:

Article

Cost-Effectiveness of Pazopanib in Advanced Soft Tissue Sarcoma in the United Kingdom.

Published in:

2014

By:

Amdahl, Jordan;
Manson, Stephanie C.;
Isbell, Robert;
Chit, Ayman;
Diaz, Jose;
Lewis, Lily;
Delea, Thomas E.

Publication type:

Journal Article

Cost-Effectiveness of Pazopanib in Advanced Soft Tissue Sarcoma in the United Kingdom.

Published in:

Sarcoma, 2014, p. 1, doi. 10.1155/2014/481071

By:

Amdahl, Jordan;
Manson, Stephanie C.;
Isbell, Robert;
Chit, Ayman;
Diaz, Jose;
Lewis, Lily;
Delea, Thomas E.

Publication type:

Article

Cost-effectiveness of dabrafenib and trametinib in combination as adjuvant treatment of BRAF V600E/K mutation-positive melanoma from a US healthcare payer perspective.

Published in:

2019

By:

Gerbasi, Margaret E.;
Stellato, Daniel;
Ghate, Sameer R.;
Ndife, Briana;
Moynahan, Aaron;
Mishra, Dinesh;
Gunda, Praveen;
Koruth, Roy;
Delea, Thomas E.

Publication type:

journal article

Healthcare utilization and costs among relapsed or refractory multiple myeloma patients on carfilzomib or pomalidomide as monotherapy or in combination with dexamethasone.

Published in:

2019

By:

Hagiwara, May;
Panjabi, Sumeet;
Sharma, Arati;
Delea, Thomas E.

Publication type:

journal article

Cost-effectiveness of brentuximab vedotin plus chemotherapy as frontline treatment of stage III or IV classical Hodgkin lymphoma.

Published in:

Journal of Medical Economics, 2019, v. 22, n. 2, p. 117, doi. 10.1080/13696998.2018.1542599

By:

Delea, Thomas E.;
Sharma, Arati;
Grossman, Aaron;
Eichten, Caitlin;
Fenton, Keenan;
Josephson, Neil;
Richhariya, Akshara;
Moskowitz, Alison J.

Publication type:

Article

Healthcare resource utilization and costs in patients with newly diagnosed acute myeloid leukemia.

Published in:

Journal of Medical Economics, 2018, v. 21, n. 11, p. 1119, doi. 10.1080/13696998.2018.1513847

By:

Hagiwara, May;
Sharma, Arati;
Chung, Karen C.;
Delea, Thomas E.

Publication type:

Article

Cost-effectiveness of brentuximab vedotin plus chemotherapy as frontline treatment of stage III or IV classical Hodgkin lymphoma.

Published in:

2018

By:

Delea, Thomas E;
Sharma, Arati;
Grossman, Aaron;
Eichten, Caitlin;
Fenton, Keenan;
Josephson, Neil;
Richhariya, Akshara;
Moskowitz, Alison J

Publication type:

journal article

Healthcare resource utilization and costs in patients with newly diagnosed acute myeloid leukemia.

Published in:

2018

By:

Hagiwara, May;
Sharma, Arati;
Chung, Karen C;
Delea, Thomas E

Publication type:

journal article

Risk of Asthma Exacerbation, Asthma-Related Health Care Utilization and Costs, and Adherence to Controller Therapy in Patients with Asthma Receiving Fluticasone Propionate/Salmeterol Inhalation Powder 100 μg/50 μg Versus Mometasone Furoate Inhalation Powder

Published in:

Journal of Asthma, 2013, v. 50, n. 3, p. 287, doi. 10.3109/02770903.2012.754028

By:

Hagiwara, May;
Delea, Thomas E.;
Stanford, Richard H.

Publication type:

Article

Retrospective Comparison of Early versus Late Treatment with Fluticasone Propionate/Salmeterol After an Asthma Exacerbation.

Published in:

Journal of Asthma, 2011, v. 48, n. 7, p. 721, doi. 10.3109/02770903.2011.599908

By:

Hagiwara, May;
Delea, Thomas E.;
Stanford, Richard H.

Publication type:

Article

Utilization of intravenous bisphosphonates in patients with bone metastases secondary to breast, lung, or prostate cancer.

Published in:

Supportive Care in Cancer, 2014, v. 22, n. 1, p. 103, doi. 10.1007/s00520-013-1951-z

By:

Hagiwara, May;
Delea, Thomas E.;
Cong, Ze;
Chung, Karen

Publication type:

Article

Outcomes, utilization, and costs among thalassemia and sickle cell disease patients receiving deferoxamine therapy in the United States.

Published in:

American Journal of Hematology, 2008, v. 83, n. 4, p. 263, doi. 10.1002/ajh.21049

By:

Delea, Thomas E.;
Hagiwara, May;
Thomas, Simu K.;
Baladi, Jean-Francois;
Phatak, Pradyumna D.;
Coates, Thomas D.

Publication type:

Article

Preferences of Canadian Patients and Physicians for Treatment of HR+/HER2-Advanced Breast Cancer.

Published in:

Current Oncology, 2021, v. 28, n. 1, p. 491, doi. 10.3390/curroncol28010051

By:

Stellato, Daniel;
Thabane, Marroon;
Eichten, Caitlin;
Delea, Thomas E.

Publication type:

Article

Real-World Evaluation of Treatment Patterns, Healthcare Costs, and Healthcare Resource Utilization Among Patients with Non-small Cell Lung Cancer in the US Receiving Sotorasib.

Published in:

Advances in Therapy, 2024, v. 41, n. 12, p. 4648, doi. 10.1007/s12325-024-03020-7

By:

Sultan, Ihtisham;
Waterhouse, David M.;
Chopra, Divyan;
Lonshteyn, Alexander;
Weycker, Derek;
Delea, Thomas E.;
Stollenwerk, Björn

Publication type:

Article

Use of thiazolidinediones and risk of heart failure in people with type 2 diabetes: a retrospective cohort study.

Published in:

2003

By:

Delea, Thomas E.;
Edelsberg, John S.;
Hagiwara, May;
Oster, Gerry;
Phillips, Lawrence S.

Publication type:

journal article

Quality-Adjusted Survival with Ribociclib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Postmenopausal Women with HR±HER2- Advanced Breast Cancer in the MONALEESA-3 Trial.

Published in:

2022

By:

Jerusalem, Guy;
Delea, Thomas E.;
Martin, Migule;
Laurentiis, Michelino De;
Nusch, Arnd;
Beck, J. Thaddeus;
Arlene Chan;
Seock-Ah Im;
Neven, Patrick;
Lonshteyn, Alexander;
Chandiwana, David;
Lanoue, Brad;
Fasching, Peter A.;
De Laurentiis, Michelino;
Chan, Arlene;
Im, Seock-Ah

Publication type:

journal article

Cost-Effectiveness of Zoledronic Acid Plus Endocrine Therapy in Premenopausal Women With Hormone-Responsive Early Breast Cancer.

Published in:

Clinical Breast Cancer, 2010, v. 10, n. 4, p. 267, doi. 10.3816/CBC.2010.n.034

By:

Delea, Thomas E.;
Taneja, Charu;
Sofrygin, Oleg;
Kaura, Satyin;
Gnant, Michael

Publication type:

Article

Cost-effectiveness of pazopanib versus sunitinib for metastatic renal cell carcinoma in the United Kingdom.

Published in:

PLoS ONE, 2017, v. 12, n. 6, p. 1, doi. 10.1371/journal.pone.0175920

By:

Amdahl, Jordan;
Sharma, Arati;
Delea, Thomas E.;
Diaz, Jose;
Park, Jinhee;
Chandiwana, David

Publication type:

Article

Cost-effectiveness of alternate strategies for childhood immunization against meningococcal disease with monovalent and quadrivalent conjugate vaccines in Canada.

Published in:

PLoS ONE, 2017, v. 12, n. 5, p. 1, doi. 10.1371/journal.pone.0175721

By:

Delea, Thomas E.;
Weycker, Derek;
Atwood, Mark;
Neame, Dion;
Alvarez, Fabián P.;
Forget, Evelyn;
Langley, Joanne M.;
Chit, Ayman

Publication type:

Article

Matching-Adjusted Indirect Comparison of Ribociclib Plus Fulvestrant versus Palbociclib Plus Letrozole as First-Line Treatment of HR+/HER2− Advanced Breast Cancer.

Published in:

Cancer Management & Research, 2021, v. 13, p. 8179, doi. 10.2147/CMAR.S325043

By:

Fasching, Peter A;
Delea, Thomas E;
Lu, Yen-Shen;
De Boer, Richard;
Hurvitz, Sara A;
Moynahan, Aaron;
Chandiwana, David;
Lanoue, Brad;
Hu, Huilin;
Thuerigen, Astrid;
O'Shaughnessy, Joyce

Publication type:

Article

Consequences and costs of noncompliance with iron chelation therapy in patients with transfusion-dependent thalassemia: a literature review.

Published in:

Transfusion, 2007, v. 47, n. 10, p. 1919, doi. 10.1111/j.1537-2995.2007.01416.x

By:

Delea, Thomas E.;
Edelsberg, John;
Sofrygin, Oleg;
Thomas, Simu K.;
Baladi, Jean-Francois;
Phatak, Pradyumna D.;
Coates, Thomas D.

Publication type:

Article

Valsartan versus lisinopril or extended-release metoprolol in preventing cardiovascular and renal events in patients with hypertension.

Published in:

American Journal of Health-System Pharmacy, 2007, v. 64, n. 11, p. 1187, doi. 10.2146/ajhp060380

By:

Delea, Thomas E.;
Taneja, Charu;
Moynahan, Aaron;
Thomas, Simu K.;
Frech-Tamas, Feride;
Oster, Gerry

Publication type:

Article

Cost effectiveness of letrozole versus anastrozole in postmenopausal women with HR early-stage breast cancer.

Published in:

Current Medical Research & Opinion, 2010, v. 26, n. 10, p. 2315, doi. 10.1185/03007995.2010.510784

By:

Michael Lipsitz;
Thomas E. Delea;
Amy Guo

Publication type:

Article

Adherence with levodopa/carbidopa/entacapone versus levodopa/carbidopa and entacapone as separate tablets in patients with Parkinson's disease.

Published in:

2010

By:

Delea, Thomas E;
Thomas, Simu K;
Hagiwara, May;
Mancione, L

Publication type:

Journal Article

Adherence with levodopa/carbidopa/entacapone versus levodopa/carbidopa and entacapone as separate tablets in patients with Parkinsons disease.

Published in:

Current Medical Research & Opinion, 2010, v. 26, n. 7, p. 1543, doi. 10.1185/03007991003780628

By:

Thomas E. Delea;
Simu K. Thomas;
May Hagiwara;
L. Mancione

Publication type:

Article

Retrospective study of the association between transfusion frequency and potential complications of iron overload in patients with myelodysplastic syndrome and other acquired hematopoietic disorders.

Published in:

Current Medical Research & Opinion, 2009, v. 25, n. 1, p. 139, doi. 10.1185/03007990802565867

By:

Thomas E. Delea;
May Hagiwara;
Pradyumna D. Phatak

Publication type:

Article

Healthcare use and costs in patients with chronic bronchitis initiating maintenance therapy with fluticasone/salmeterol vs other inhaled maintenance therapies.

Published in:

Current Medical Research & Opinion, 2009, v. 25, n. 1, p. 1, doi. 10.1185/03007990802534020

By:

Thomas E. Delea;
May Hagiwara;
Anand A. Dalal;
Richard H. Stanford;
Christopher M. Blanchette

Publication type:

Article

Association between adherence with fixed dose combination fluticasone propionate/salmeterol on asthma outcomes and costs*.

Published in:

2008

By:

Delea TE;
Stanford RH;
Hagiwara M;
Stempel DA;
Delea, Thomas E;
Stanford, Richard H;
Hagiwara, May;
Stempel, David A

Publication type:

journal article

Association between adherence with fixed dose combination fluticasone propionate/salmeterol on asthma outcomes and costs.

Published in:

Current Medical Research & Opinion, 2008, v. 24, n. 12, p. 3435, doi. 10.1185/03007990802557344

By:

Thomas E. Delea;
Richard H. Stanford;
May Hagiwara;
David A. Stempel

Publication type:

Article

Association Between Use of Thiazolidinediones and Costs of Heart Failure in Patients with Type 2 Diabetes.

Published in:

Diabetes, 2007, v. 56, p. A317

By:

Delea, Thomas E.;
Hagiwara, May;
Plauschinat, Craig A.

Publication type:

Article

Health-care utilization and costs with fluticasone propionate and fluticasone propionate/salmeterol in asthma patients at risk for exacerbations.

Published in:

Allergy & Asthma Proceedings, 2014, v. 35, n. 1, p. 54, doi. 10.2500/aap.2014.35.3720

By:

Hagiwara, May;
Delea, Thomas E.;
Stanford, Richard H.

Publication type:

Article

Stepping down to fluticasone propionate or a lower dose of fluticasone propionate/salmeterol combination in asthma patients recently initiating combination therapy.

Published in:

Allergy & Asthma Proceedings, 2010, v. 31, n. 3, p. 203, doi. 10.2500/aap.2010.31.3359

By:

Hagiwara, May;
Delea, Thomas E.;
Stanford, Richard H.;
Stempel, David A.

Publication type:

Article

Adding salmeterol to fluticasone propionate or increasing the dose of fluticasone propionate in patients with asthma.

Published in:

Allergy & Asthma Proceedings, 2010, v. 31, n. 3, p. 211, doi. 10.2500/aap.2010.31.3360

By:

Delea, Thomas E.;
Hagiwara, May;
Stempel, David A.;
Stanford, Richard H.

Publication type:

Article

Valsartan versus lisinopril or metoprolol to prevent cardiovascular events in patients with hypertension

Published in:

2005

By:

Delea, Thomas E.;
Thomas, Simu K.;
Moynihan, Aaron;
Frech, Feride;
Oster, Gerry

Publication type:

Abstract

Lifetime Costs for Treated Follicular Lymphoma Patients in the US.

Published in:

PharmacoEconomics, 2021, v. 39, n. 10, p. 1163, doi. 10.1007/s40273-021-01052-3

By:

Eichten, Caitlin;
Ma, Qiufei;
Delea, Thomas E.;
Hagiwara, May;
Ramos, Roberto;
Iorga, Şerban R.;
Zhang, Jie;
Maziarz, Richard T.

Publication type:

Article

Cost Effectiveness of Ribociclib in Combination with Fulvestrant for the Treatment of Postmenopausal Women with HR+/HER2− Advanced Breast Cancer Who Have Received No or Only One Prior Line of Endocrine Therapy: A Canadian Healthcare Perspective.

Published in:

PharmacoEconomics, 2021, v. 39, n. 9, p. 1045, doi. 10.1007/s40273-021-01027-4

By:

Stellato, Daniel;
Thabane, Marroon E.;
Park, Jinhee;
Chandiwana, David;
Delea, Thomas E.

Publication type:

Article

Cost Effectiveness of Ribociclib Plus a Nonsteroidal Aromatase Inhibitor in Pre-/Perimenopausal, HR+ and HER2- Advanced Breast Cancer: A Canadian Healthcare Perspective.

Published in:

2021

By:

Stellato, Daniel;
Thabane, Marroon E.;
Chandiwana, David;
Park, Jinhee;
Delea, Thomas E.

Publication type:

journal article

Cost Effectiveness of Blinatumomab Versus Inotuzumab Ozogamicin in Adult Patients with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia in the United States.

Published in:

2019

By:

Delea, Thomas E.;
Zhang, Xinke;
Amdahl, Jordan;
Boyko, Diana;
Dirnberger, Franziska;
Campioni, Marco;
Cong, Ze

Publication type:

journal article

Budget Impact Analysis of PCSK9 Inhibitors for the Management of Adult Patients with Heterozygous Familial Hypercholesterolemia or Clinical Atherosclerotic Cardiovascular Disease.

Published in:

2018

By:

Mallya, Usha;
Koren, Andrew;
Boklage, Susan;
Delea, Thomas;
Mullins, C.;
Mallya, Usha G;
Boklage, Susan H;
Delea, Thomas E;
Mullins, C Daniel

Publication type:

journal article

Cost effectiveness of once-daily oral chelation therapy with deferasirox versus infusional deferoxamine in transfusion-dependent thalassaemia patients: US healthcare system perspective.

Published in:

2007

By:

Delea, Thomas E.;
Sofrygin, Oleg;
Thomas, Simu K.;
Baladi, Jean-Francois;
Phatak, Pradyumna D.;
Coates, Thomas D.

Publication type:

journal article

Cost-Effectiveness of Lapatinib plus Letrozole in Post-Menopausal Women with Hormone Receptor- and HER2-Positive Metastatic Breast Cancer.

Published in:

2013

By:

Delea, Thomas E.;
Hawkes, Carol;
Amonkar, Mayur M.;
Lykopoulos, Konstantinos;
Johnston, Stephen R. D.

Publication type:

Journal Article

From Triple- to Penta-Exposed Multiple Myeloma: A Real-World Study in a Medicare Population.

Published in:

Oncology & Therapy, 2024, v. 12, n. 3, p. 565, doi. 10.1007/s40487-024-00291-6

By:

Delea, Thomas E.;
Ma, Qiufei;
Kroog, Glenn S.;
Ge, Wenzhen;
Moynahan, Aaron;
Sabater Anaya, Natalia;
Rodriguez Lorenc, Karen;
Song, Xue

Publication type:

Article

Survival Outcomes in Patients With Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Receiving Third- or Subsequent Line (3L) Treatment.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S311, doi. 10.1016/j.clml.2017.07.111

By:

Stellato, Daniel R.;
McGarry, Lisa;
Huang, Hui;
Hastings, Shaina;
Delea, Thomas E.;
Lipton, Jeffrey H.

Publication type:

Article

Retrospective Study of the Prevalence, Predictors, and Consequences of Nonadherence With Lapatinib in Women With Metastatic Breast Cancer Who Were Previously Treated With Trastuzumab.

Published in:

2014

By:

Delea, Thomas E.;
Kartashov, Alex;
Sharma, Puza P.

Publication type:

Journal Article

The association between adherence to levodopa/carbidopa/entacapone therapy and healthcare utilization and costs among patients with Parkinson's disease: a retrospective claims-based analysis.

Published in:

2011

By:

Delea TE;
Thomas SK;
Hagiwara M;
Delea, Thomas E;
Thomas, Simu K;
Hagiwara, May

Publication type:

journal article

Estimating outcomes and cost effectiveness using a single-arm clinical trial: ofatumumab for double-refractory chronic lymphocytic leukemia.

Published in:

Cost Effectiveness & Resource Allocation, 2017, v. 15, p. 1, doi. 10.1186/s12962-017-0071-x

By:

Hatswell, Anthony J.;
Thompson, Gwilym J.;
Maroudas, Penny A.;
Sofrygin, Oleg;
Delea, Thomas E.

Publication type:

Article